Search
Biropepimut-S
go.drugbank.com/drugs/DB14816InvestigationalBiropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral
HGS-TR2J
go.drugbank.com/drugs/DB05895ExperimentalHGS-TR2J is a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.
Revexepride
go.drugbank.com/drugs/DB20324InvestigationalThe usage of the INN stem '-pride' in the name indicates that Revexepride is a sulpiride derivative and analogue.
Levcromakalim
go.drugbank.com/drugs/DB21154InvestigationalThe usage of the INN stem '-kalim' in the name indicates that Levcromakalim is a potassium channel activator, antihypertensive.
Luvometinib
go.drugbank.com/drugs/DB21696InvestigationalThe usage of the INN stem '-tinib' in the name indicates that Luvometinib is a tyrosine kinase inhibitor.
Pebezertinib
go.drugbank.com/drugs/DB21705InvestigationalThe usage of the INN stem '-ertinib' in the name indicates that Pebezertinib is a epidermal growth factor receptor (EGFR) inhibitor.
Inlexisertib
go.drugbank.com/drugs/DB21713InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Inlexisertib is a serine/threonine kinase inhibitor.
MLN3897
go.drugbank.com/drugs/DB06505ExperimentalMLN3897, a novel CCR1 inhibitor, disrupts osteoclast formation and blocks the interaction between multiple myeloma cells and osteoclasts.
Synonyms: (4S)-4-(4-CHLOROPHENYL)-1-((3E)-3-(9-(1-HYDROXY-1-METHYL-ETHYL)-5H-(1)BENZOXEPINO(3,4-B)PYRIDIN-11-YLIDENE)PROPYL)-3,3-DIMETHYL-PIPERIDIN-4-OL